Proarrhythmia
 | This article needs more reliable medical references for verification or relies too heavily on primary sources. (May 2019) |  |
Proarrhythmia is a new or more frequent occurrence of pre-existing arrhythmias, paradoxically precipitated by antiarrhythmic therapy, which means it is a side effect associated with the administration of some existing antiarrhythmic drugs, as well as drugs for other indications. In other words, it is a tendency of antiarrhythmic drugs to facilitate emergence of new arrhythmias.
Types of proarrhythmia
[edit]According to the Vaughan Williams classification (VW) of antiarrhythmic drugs, there are 3 main types of Proarrhythmia during treatment with various antiarrhythmic drugs for Atrial Fibrillation or Atrial flutter:
Ventricular proarrhythmia
[edit]- Torsades de pointes (VW type IA and type III drugs)
- Sustained monomorphic ventricular tachycardia (usually VW type IC drugs)
- Sustained polymorphic ventricular tachycardia/ventricular fibrillation without long QT (VW types IA, IC, and III drugs)
Atrial proarrhythmia
[edit]- Conversion of atrial fibrillation to flutter (usually VW type IC drugs or amiodarone). May be a desired effect.
- Increase of defibrillation threshold (a potential problem with VW type IC drugs)
- Provocation of recurrence (probably VW types IA, IC and III drugs). It is rare.
Abnormalities of conduction or impulse formation
[edit]- Sinus node dysfunction, atrioventricular block (almost all drugs)
- Accelerate conduction over accessory pathway (digoxin, intravenous verapamil, or diltiazem)
- Acceleration of ventricular rate during atrial fibrillation (VW type IA and type IC drugs).
Increased risk
[edit]- Presence of structural heart disease, especially LV systolic dysfunction.
- Class IC agents.
- Increased age.
- Females.
Clinical pointers
[edit]Class IA drugs
[edit]- Dose independent, occurring at normal levels.
- Follow QT interval, keep ms.
Class IC drugs
[edit]- May be provoked by increased heart rate.
- Exercise stress tests after loading.
Class III drugs
[edit]- Dose dependent.
- Follow bradycardia, prolonged QT closely.
References
[edit]External links
[edit]- Roden DM (August 1998). "Mechanisms and management of proarrhythmia". Am. J. Cardiol. 82 (4A): 49I – 57I. doi:10.1016/S0002-9149(98)00472-X. PMID 9737654.